20/08/2026
In silico screening is great at finding promising molecules - docking scores can sift thousands of candidates fast. But here's what trips up pharma and biotech applicants: 🧬
The computational data that's good enough to guide discovery often isn't enough to support a patent claim.
To an examiner, a docking study is just a hypothesis with numbers attached - not proof the compound actually does what you say. And the sting? Sufficiency is judged as of your filing date. File on predictions, run your lab assays six months later, and that data usually can't be added to save the application.
File too early and your best result may arrive too late to help.
Our latest blog breaks down why prediction isn't proof — and how to time your bench work right. 👇
https://techmatchinc.com/in-silico-isnt-enough-why-computational-predictions-alone-wont-carry-a-philippine-pharma-or-biotech-patent/
Computer-aided drug discovery has changed how research teams find promising molecules. Docking scores, molecular dynamics simulations, and binding-energy calculations can screen thousands of candidates in the time it once took to test a handful at the bench. For research institutions and biotech sta...